Our previous studies provided evidence that CTT induces substantial release of tumor neoantigens 9 and damage-associated molecular patterns (DAMPs), including HSP705 and DNA, which may directly stimulate BCR and TLR signaling, respectively. The gene discussed is BCR; the disease is neoplasm.